- Home
- DNA vs GCMG Comparison
DNA vs GCMG Comparison
Compare DNA & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- GCMG
- Stock Information
- Founded
- DNA 2008
- GCMG 1971
- Country
- DNA United States
- GCMG United States
- Employees
- DNA N/A
- GCMG N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- GCMG Finance/Investors Services
- Sector
- DNA Health Care
- GCMG Finance
- Exchange
- DNA Nasdaq
- GCMG Nasdaq
- Market Cap
- DNA 731.1M
- GCMG 631.4M
- IPO Year
- DNA N/A
- GCMG N/A
- Fundamental
- Price
- DNA $14.93
- GCMG $11.73
- Analyst Decision
- DNA Strong Sell
- GCMG Buy
- Analyst Count
- DNA 1
- GCMG 4
- Target Price
- DNA $9.00
- GCMG $15.13
- AVG Volume (30 Days)
- DNA 1.7M
- GCMG 706.9K
- Earning Date
- DNA 11-11-2025
- GCMG 11-07-2025
- Dividend Yield
- DNA N/A
- GCMG 3.74%
- EPS Growth
- DNA N/A
- GCMG N/A
- EPS
- DNA N/A
- GCMG 0.19
- Revenue
- DNA $230,815,000.00
- GCMG $533,097,999.00
- Revenue This Year
- DNA N/A
- GCMG $4.88
- Revenue Next Year
- DNA $14.41
- GCMG $11.78
- P/E Ratio
- DNA N/A
- GCMG $63.32
- Revenue Growth
- DNA 25.21
- GCMG 15.56
- 52 Week Low
- DNA $5.00
- GCMG $10.91
- 52 Week High
- DNA $16.85
- GCMG $14.48
- Technical
- Relative Strength Index (RSI)
- DNA 61.79
- GCMG 32.59
- Support Level
- DNA $10.82
- GCMG $11.67
- Resistance Level
- DNA $16.82
- GCMG $12.03
- Average True Range (ATR)
- DNA 1.11
- GCMG 0.26
- MACD
- DNA 0.40
- GCMG -0.11
- Stochastic Oscillator
- DNA 69.38
- GCMG 4.82
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.